Retracted: 2-Tellurium-bridged β-cyclodextrin, a thioredoxin reductase inhibitor, sensitizes human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-κB suppression
- DOI
- 10.1093/carcin/bgq234
- Published
- 2010-11-16
- Container
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/carcin/bgq234,
title = {Retracted: 2-Tellurium-bridged β-cyclodextrin, a thioredoxin reductase inhibitor, sensitizes human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-κB suppression},
author = {Tingting Lin and Zhiying Ding and Nan Li and Jiayun Xu and Guimin Luo and Junqiu Liu and Jiacong Shen},
year = {2010},
journal = {Carcinogenesis},
doi = {10.1093/carcin/bgq234},
url = {https://doi.org/10.1093/carcin/bgq234}
}RIS
TY - JOUR TI - Retracted: 2-Tellurium-bridged β-cyclodextrin, a thioredoxin reductase inhibitor, sensitizes human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-κB suppression AU - Tingting Lin AU - Zhiying Ding AU - Nan Li AU - Jiayun Xu AU - Guimin Luo AU - Junqiu Liu AU - Jiacong Shen PY - 2010 JO - Carcinogenesis DO - 10.1093/carcin/bgq234 UR - https://doi.org/10.1093/carcin/bgq234 ER -
APA
Lin, T., Ding, Z., Li, N., Xu, J., Luo, G., Liu, J., & Shen, J. (2010). Retracted: 2-Tellurium-bridged β-cyclodextrin, a thioredoxin reductase inhibitor, sensitizes human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-κB suppression. Carcinogenesis. https://doi.org/10.1093/carcin/bgq234
Source records
- crossref · retrieved 2026-11-04T14:29:09.626Z